Roll, Wolfgang
Weckesser, Matthias
Seifert, Robert
Bodei, Lisa
Rahbar, Kambiz http://orcid.org/0000-0002-4591-4055
Funding for this research was provided by:
Westfälische Wilhelms-Universität Münster
Article History
Received: 6 January 2021
Accepted: 5 April 2021
First Online: 26 April 2021
Declarations
:
: Not applicable.
: Not applicable.
: KR reports receiving consultation or lectureship fees from ABX, AAA, Bayer, AMGEN, SIRTEX, and Janssen Cielag. LB reports on uncompensated consultancy/speaker activity for AAA-Novartis, Ipsen, ITM, Clovis Oncology, Iba, Curium, Molecular Target Technologies, and a research grant from AAA-Novartis. The other authors declare no competing interests.